Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Locations section updated to reflect changes in trial sites, adding and removing site entries across the U.S. and Canada (California, Illinois, Indiana, Michigan, Pennsylvania, Alberta, Ontario). The revision tag shows v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-24T14:49:53.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications section now notes that items are automatically filled from PubMed. The revision version is updated to v3.3.2, replacing the previous PubMed description (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T14:51:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding notice about NIH operating status, an administrative item that does not affect trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:32:26.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The study page shows an updated last update date and a Completed status, while core details—eligibility criteria, Primary/Secondary outcomes, and locations—remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:06:43.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated page with newer cancer staging terms, location/center details, dates, and revision version; older staging terms, location, date, and revision removed.
    Difference
    4%
    Check dated 2025-10-06T08:24:10.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-29T05:10:44.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.